News Releases
AVON, Conn., Nov 02, 2007 (BUSINESS WIRE) -- Magellan Health Services, Inc. (Nasdaq: MGLN) today reported net income of $25.1 million, or $.63 per diluted common share, and segment profit of $57.4 million for the third quarter of fiscal year 2007. The Company also said that it now expects to generate segment profit in the range of $215 million to $225 million for 2007.
Financial Results
For the quarter ended September 30, 2007, the Company reported net revenue of $558.1 million and net income of $25.1 million, or $.63 per diluted common share. For the prior year quarter, net revenue was $429.5 million and net income was $21.2 million or $.54 per diluted common share. Segment profit (which represents income from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, income taxes and minority interest) for the current year quarter was $57.4 million, compared with $54.6 million in the prior year quarter.
For the nine months ended September 30, 2007, the Company reported net revenue of $1.50 billion and net income of $62.9 million, or $1.59 per diluted common share. For the prior year period, the Company reported net revenue of $1.23 billion and net income of $63.8 million, or $1.65 per diluted common share. Segment profit for the first nine months of 2007 was $157.0 million versus $154.0 million for the prior year period.
See the attached tables detailing the Company's operating results, including results by segment.
The Company ended the quarter with unrestricted cash and investments of $300.3 million. Cash flow from operations for the nine months ended September 30, 2007 was $152.5 million compared with $132.0 million for the comparable period in the prior year.
Steven J. Shulman, chairman and chief executive officer, said, "In addition to another strong financial performance, certainly a highlight in the quarter was the successful implementation of the Maricopa County public sector contract, which went live on September 1. This effort involved hundreds of Magellan employees whose goal was to ensure a smooth transition for the individuals served by the program, their families and the community as a whole, and I am pleased to report that the feedback from our stakeholders, including our customer, has been very positive. Our success in this effort is indicative of our expertise in implementing large, complex contracts with great care for the people who depend on them, and doing so in a fiscally responsible manner."
"From a financial standpoint, we are generally very pleased with our results for the quarter. Based on one month of results, the Maricopa contract is performing better than anticipated and costs associated with the start-up have been lower than originally estimated. Results for our health plan behavioral business were particularly strong this quarter, while performance for ICORE, our specialty pharmaceuticals segment, continued to lag our expectations. As a result, we are retooling our approach to marketing and sales for ICORE to bolster our efforts to capitalize on the growth opportunity that we continue to believe exists in the specialty drug arena," Shulman said.
"Again this quarter we generated strong cash flows and continue to maintain a very robust balance sheet. With regard to our capital structure, our strategy remains consistent. We believe strongly that shareholder value over time can best be maximized by continuing Magellan's expansion and further diversification in the specialty managed care marketplace. Therefore, we remain focused primarily on capital deployment tactics that further that objective, namely acquisition opportunities," Shulman added.
Outlook
The Company's previous guidance of segment profit for 2007, including the estimated impact of the Maricopa County contract, was $180 million to $200 million. On the basis of its third quarter performance, the Company now expects to generate full-year segment profit for 2007 in the range of $215 million to $225 million and earnings per diluted common share in the range of $2.13 to $2.39.
Mark S. Demilio, chief financial officer, said, "Our revised guidance for 2007 reflects particularly strong results associated with our behavioral business, due primarily to favorable care trend in the health plan segment and the favorable initial results of the Maricopa contract. Based on our experience in 2007, we believe that the care trend in our health plan segment is now five percent to seven percent."
"Looking ahead to 2008, we anticipate providing guidance in December as we typically do; however, in the meantime, we have preliminarily estimated the impact of certain factors affecting next year's results. Such factors include sold new business, including the full-year impact of the radiology risk and Maricopa contracts that were implemented in 2007, and unsold new business to be implemented in 2008, offset by the impact of previously announced contract terminations as well as the net impact of certain rate renewals in the behavioral business. We expect the net impact of these items will result in 2008 segment profit that will be slightly less than our expected segment profit for this year. We will provide more color on these and other items when we provide guidance in December," Demilio said.
Earnings Results Conference Call
A conference call will be held to discuss the Company's financial results at 9:30 a.m. Eastern time on Friday, November 2. To participate in the conference call, interested parties should call 1-888-390-4698 and reference the passcode Third Quarter Earnings and conference leader Steve Shulman approximately 15 minutes before the start of the call.
The conference call also will be available via a live Webcast at the investor relations page of Magellan's Web site, www.MagellanHealth.com.
A taped replay of the conference call will be available for one week following the call. The call-in numbers for the replay are 866-491-9108 and 203-369-1739 (from outside the U.S.).
Those who plan to access the Webcast are encouraged to read Magellan's Annual Report on Form 10-K for the year ended December 31, 2006, filed with the Securities and Exchange Commission on February 28, 2007, for material information regarding Magellan's operational and financial results, including the section entitled "Risk Factors."
About Magellan: Headquartered in Avon, Conn., Magellan Health Services, Inc. (Nasdaq:MGLN) is a leading specialty health care management organization. Its customers include health plans, corporations and government agencies.
Cautionary Statement: This release contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, as amended, that involve a number of risks and uncertainties. All statements, other than statements of historical information provided herein, may be deemed to be forward-looking statements including, without limitation, statements regarding estimates of segment profit, net income and earnings per share. These statements are based on management's analysis, judgment, belief and expectation only as of the date hereof, and are subject to uncertainty and changes in circumstances. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "may," "should," "could," "estimate," "intend" and other similar expressions are intended to identify forward-looking statements. Actual results could differ materially due to, among other things, the possible election of certain of the Company's customers to manage the healthcare services of their members directly; changes in rates paid to and/or by the Company by customers and/or providers; higher utilization of health care services by the Company's risk members; delays, higher costs or inability to implement new business or other Company initiatives; the impact of changes in the contracting model for Medicaid contracts; termination or non-renewal of customer contracts; the impact of new or amended laws or regulations; governmental inquiries; litigation; competition; operational issues; health care reform; and general business conditions. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the "Risk Factors" section included within the Company's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date of this release. Segment profit information referred to herein may be considered a non-GAAP financial measure. Further information regarding this measure, including the reasons management considers this information useful to investors, is included in the Company's most recent Annual Report on Form 10-K and subsequent reports on Form 10-Q filed with the SEC.
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share amounts)
Three Months Ended Nine Months Ended
September 30, September 30,
-------------------- ------------------------
2006 2007(1) 2006 2007(1)
--------- --------- ----------- -----------
Net revenue $429,487 $558,076 $1,229,016 $1,497,948
Cost and expenses:
Cost of care 271,905 369,008 804,446 957,045
Cost of goods sold 15,212 37,341 15,212 108,052
Direct service costs
and other operating
expenses (2) 96,661 102,468 276,827 298,482
Equity in earnings of
unconsolidated
subsidiaries - - (390) -
Depreciation and
amortization 13,096 14,393 35,086 41,550
Interest expense 1,807 1,571 5,497 5,027
Interest income (4,280) (6,434) (13,418) (17,140)
Gain on sale of assets - - (5,148) -
--------- --------- ----------- -----------
394,401 518,347 1,118,112 1,393,016
--------- --------- ----------- -----------
Income from continuing
operations before
income taxes and
minority interest 35,086 39,729 110,904 104,932
Provision for income
taxes 13,890 14,712 47,169 41,930
--------- --------- ----------- -----------
Income from continuing
operations before
minority interest 21,196 25,017 63,735 63,002
Minority interest, net (40) (47) (40) 145
--------- --------- ----------- -----------
Net income 21,236 25,064 63,775 62,857
Other comprehensive
income 186 48 562 40
--------- --------- ----------- -----------
Comprehensive income $ 21,422 $ 25,112 $ 64,337 $ 62,897
========= ========= =========== ===========
Weighted average number
of common shares
outstanding -- basic 37,096 39,193 36,925 38,759
========= ========= =========== ===========
Weighted average number
of common shares
outstanding -- diluted 39,023 39,849 38,569 39,654
========= ========= =========== ===========
Net income per common
share -- basic $ 0.57 $ 0.64 $ 1.73 $ 1.62
========= ========= =========== ===========
Net income per common
share -- diluted $ 0.54 $ 0.63 $ 1.65 $ 1.59
========= ========= =========== ===========
(1) For a more detailed discussion of Magellan's results for the
quarter ended September 30, 2007, refer to the Company's Quarterly
Report on Form 10-Q which will be filed with the SEC on November 2,
2007, and the live broadcast or taped replay of the Company's
earnings conference call on November 2, 2007, which will be available
at www.MagellanHealth.com.
(2) Includes stock compensation expense of $8,939 and $8,172 for the
three months ended September 30, 2006 and 2007, respectively, and
$21,033 and $22,662 for the nine months ended September 30, 2006 and
2007, respectively.
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
Nine Months Ended
September 30,
----------------------
2006 2007
---------- ----------
Cash flows from operating activities:
Net income $ 63,775 $ 62,857
Adjustments to reconcile net income to net cash
provided by operating activities:
Gain on sale of assets (5,148) -
Depreciation and amortization 35,086 41,550
Equity in earnings of unconsolidated
subsidiaries (390) -
Non-cash interest expense 1,042 1,042
Non-cash stock compensation expense 21,033 22,662
Non-cash income tax expense 42,232 38,987
Cash flows from changes in assets and
liabilities, net of effects from
acquisitions of businesses:
Restricted cash 22,241 (48,339)
Accounts receivable, net 11,125 (3,520)
Other assets (384) (9,747)
Accounts payable and accrued liabilities (19,013) (5,411)
Medical claims payable and other medical
liabilities (39,602) 51,925
Other (39) 535
---------- ----------
Net cash provided by operating
activities 131,958 152,541
---------- ----------
Cash flows from investing activities:
Capital expenditures (14,999) (31,806)
Acquisitions and investments in businesses,
net of cash acquired (282,806) (5,277)
Proceeds from sale of assets 22,200 -
Purchase of investments (29,589) (100,883)
Maturity of investments 227,534 94,017
Proceeds from note receivable 3,000 -
---------- ----------
Net cash used in investing activities (74,660) (43,949)
---------- ----------
Cash flows from financing activities:
Payments on long-term debt and capital lease
obligations (18,929) (20,346)
Proceeds from exercise of stock options and
warrants 8,878 26,717
Other - (172)
---------- ----------
Net cash (used in) provided by financing
activities (10,051) 6,199
---------- ----------
Net increase in cash and cash equivalents 47,247 114,791
Cash and cash equivalents at beginning of
period 81,039 163,737
---------- ----------
Cash and cash equivalents at end of period $ 128,286 $ 278,528
========== ==========
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except membership amounts in millions)
Three Months Ended Nine Months Ended
September 30, September 30,
-------------------- ------------------------
2006 2007 2006 2007
--------- --------- ----------- -----------
Net revenue
- Health Plan $164,479 $159,692 $ 481,648 $ 495,940
- Employer 32,079 31,715 97,316 94,320
- Public Sector 201,586 249,510 598,551 675,703
- Radiology Benefits
Management 10,648 72,054 30,806 101,245
- Specialty
Pharmaceutical
Management 20,695 45,105 20,695 130,740
--------- --------- ----------- -----------
Total revenue 429,487 558,076 1,229,016 1,497,948
--------- --------- ----------- -----------
Cost of care
- Health Plan 95,404 85,154 271,577 278,556
- Employer 6,875 6,615 21,942 20,382
- Public Sector 169,626 223,888 510,927 598,451
- Radiology Benefits
Management - 53,351 - 59,656
--------- --------- ----------- -----------
Total cost of care 271,905 369,008 804,446 957,045
--------- --------- ----------- -----------
Cost of goods sold -
Specialty
Pharmaceutical
Management 15,212 37,341 15,212 108,052
--------- --------- ----------- -----------
Direct service costs
- Health Plan 25,754 23,525 78,169 75,476
- Employer 16,605 15,782 50,879 47,568
- Public Sector 8,928 14,468 26,269 35,015
- Radiology Benefits
Management 9,845 14,097 26,760 36,320
- Specialty
Pharmaceutical
Management 2,631 5,507 2,631 15,733
--------- --------- ----------- -----------
Total direct services
costs 63,763 73,379 184,708 210,112
--------- --------- ----------- -----------
Other operating expenses
- Corporate & Other 32,898 29,089 92,119 88,370
--------- --------- ----------- -----------
Equity in earnings of
unconsolidated
subsidiaries - Health
Plan - - (390) -
--------- --------- ----------- -----------
Stock compensation
expense (1)
- Health Plan (391) (459) (957) (1,352)
- Employer (94) (75) (246) (343)
- Public Sector (242) (313) (603) (770)
- Radiology Benefits
Management (353) (662) (887) (1,670)
- Specialty
Pharmaceutical
Management (1,308) (2,330) (1,308) (6,483)
- Corporate & Other (6,551) (4,333) (17,032) (12,044)
--------- --------- ----------- -----------
Total stock
compensation expense (8,939) (8,172) (21,033) (22,662)
--------- --------- ----------- -----------
Segment profit (loss)
- Health Plan 43,712 51,472 133,249 143,260
- Employer 8,693 9,393 24,741 26,713
- Public Sector 23,274 11,467 61,958 43,007
- Radiology Benefits
Management 1,156 5,268 4,933 6,939
- Specialty
Pharmaceutical
Management 4,160 4,587 4,160 13,438
- Corporate & Other (26,347) (24,756) (75,087) (76,326)
--------- --------- ----------- -----------
Total segment profit $ 54,648 $ 57,431 $ 153,954 $ 157,031
========= ========= =========== ===========
Reconciliation of
segment profit to
income from continuing
operations before
income taxes and
minority interest:
Segment profit $ 54,648 $ 57,431 $ 153,954 $ 157,031
Stock compensation
expense (8,939) (8,172) (21,033) (22,662)
Depreciation and
amortization (13,096) (14,393) (35,086) (41,550)
Interest expense (1,807) (1,571) (5,497) (5,027)
Interest income 4,280 6,434 13,418 17,140
Gain on sale of assets - - 5,148 -
--------- --------- ----------- -----------
Income from continuing
operations before
income taxes and
minority interest $ 35,086 $ 39,729 $ 110,904 $ 104,932
========= ========= =========== ===========
Membership
- Health Plan 25.8
- Employer 14.3
- Public Sector 2.3
- Radiology Benefits
Management 19.9
-----------
Total membership 62.3
===========
(1) Stock compensation expense is included in direct service costs and
other operating expenses; however, this amount is excluded from the
computation of segment profit since it is managed on a consolidated
basis.
SOURCE: Magellan Health Services, Inc.
Magellan Health Services, Inc.
Investors:
Melissa Rose, 877-645-6464
or
Media:
Erin Somers, 410-953-2405